Last year, there was a 15% annual increase in the operations and surgeons want more research.

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients.

Williams said she lost 34 pounds in about a year. The announcement came as part of a campaign with the company Ro, in which ...

Major employers and insurance companies are eliminating coverage for GLP-1 weight-loss drugs. Louisiana families now must ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

This opens the door to making mistakes—ones that could worsen your side effects, affect how much weight you’ll lose, or even ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal ...